Ipamorelin Tesamorelin CJC-1295 No DAC Triple Stack

Direct Anti Peptide presents the Ipamorelin Tesamorelin CJC-1295 No DAC Triple Stack — a precisely formulated research-grade peptide combination produced at ≥98% purity and analytically verified for advanced laboratory investigation. Designed for qualified researchers exploring growth hormone modulation, this triple stack delivers three complementary peptide agents within a single, convenient research unit. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

The Ipamorelin Tesamorelin CJC-1295 No DAC Triple Stack is a research peptide combination that brings together three well-characterized growth hormone-related peptides into a single cohesive research format. Each component targets distinct but complementary nodes within the growth hormone secretion axis, making this triple stack a compelling subject for researchers investigating synergistic peptide interactions, pulsatile hormone release dynamics, and downstream signaling pathways. Available for purchase online through Direct Anti Peptide, this stack is positioned for institutional and independent laboratory researchers seeking reliable, high-purity peptide materials.

Peptide Structure & Amino Acid Sequence

This triple stack comprises three structurally distinct research peptides:

• Ipamorelin — A pentapeptide growth hormone secretagogue (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that selectively stimulates growth hormone release via ghrelin receptor agonism with high receptor specificity and minimal off-target hormonal activity.
• Tesamorelin — A synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), consisting of the full 44-amino acid GHRH sequence conjugated to a trans-3-hexenoic acid moiety, enhancing stability and bioactivity in research models.
• CJC-1295 No DAC — A modified GHRH analogue (also known as Mod GRF 1-29) comprising the first 29 amino acids of GHRH with strategic amino acid substitutions at positions 2, 8, 15, and 27 to resist enzymatic degradation and extend receptor interaction duration without the drug affinity complex (DAC) modification.

Chemical & Physical Characteristics

• Format: Lyophilized white powder
• Solubility: Soluble in aqueous buffer systems under standard laboratory conditions
• Stability: Stable under recommended storage conditions prior to reconstitution
• Purity: ≥98% per component, confirmed by analytical testing
• Peptide Classes: GHRP (Ipamorelin), GHRH analogue (Tesamorelin), Modified GHRH fragment (CJC-1295 No DAC)

Purity & Analytical Verification (HPLC & MS)

Each component of the Triple Stack undergoes independent analytical verification using high-performance liquid chromatography (HPLC) and mass spectrometry (MS). HPLC profiling confirms chromatographic purity at ≥98%, while MS analysis validates the precise molecular mass and structural integrity of each peptide chain. Researchers can rely on Direct Anti Peptide’s commitment to transparent quality data, ensuring that every research unit meets the exacting standards required for reproducible scientific outcomes.

Quality Control & Lyophilization Integrity

All three peptides within this stack are individually lyophilized under controlled freeze-drying conditions to preserve structural integrity, minimize degradation, and extend shelf stability. Lyophilization removes residual moisture to levels that prevent hydrolytic breakdown during storage and transit. Batch-level quality control protocols are applied throughout manufacturing, encompassing raw material verification, in-process testing, and final product release criteria. Only batches meeting all internal specifications are approved for sale and fulfillment.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by trained research professionals operating within appropriately equipped laboratory environments. Researchers should adhere to institutional biosafety protocols, wear appropriate personal protective equipment (PPE), and consult relevant safety data documentation prior to handling. This product is not approved for administration to humans or animals and must not be used outside of a controlled research setting. Disposal must comply with applicable local, national, and institutional regulations governing research biochemicals.

Reconstitution, Packaging & Storage

The Triple Stack is supplied as lyophilized powder in sealed, sterile-appropriate vials suitable for laboratory handling. Reconstitution should be performed using validated laboratory-grade solvents appropriate to each peptide’s solubility profile, strictly within a research context and by qualified personnel. Upon receipt, store lyophilized material at −20°C in a dry, dark environment away from humidity and temperature fluctuations. Avoid repeated freeze-thaw cycles to maintain peptide stability. Refer to accompanying documentation for specific handling parameters.

Intended Research Use & Market Positioning

The Ipamorelin Tesamorelin CJC-1295 No DAC Triple Stack is designed for researchers investigating growth hormone secretagogue receptor (GHSR) pharmacology, GHRH receptor signaling, and the combined modulatory effects of stacked peptide agents on somatotropic axis activity. It is particularly relevant to studies examining pulsatile GH release patterns, receptor selectivity, and comparative peptide stability in biological research models. Direct Anti Peptide positions this product as a premium, compliance-ready research tool for scientists who require verifiable purity and consistent batch quality.

Ordering, Availability & Fulfillment

Buy the Ipamorelin Tesamorelin CJC-1295 No DAC Triple Stack online today through Direct Anti Peptide’s secure eCommerce platform. We offer competitive best-price positioning, fast order processing, and reliable international fulfillment for qualified research institutions and independent laboratories. Orders are dispatched with appropriate cold-chain packaging to preserve peptide integrity during transit. For bulk orders or institutional procurement inquiries, contact our research sales team directly.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use. Direct Anti Peptide sells this product exclusively to licensed researchers, academic institutions, and qualified laboratory professionals for in vitro and preclinical research purposes. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws governing the procurement, possession, and use of research peptides. Misuse of this product is strictly prohibited.